Nebivolol + Hydrochlorothiazide: Brands, Price & Uses in Bangladesh

Nebivolol + Hydrochlorothiazide is a fixed-dose combination indicated for the treatment of hypertension (high blood pressure), used to lower blood pressure in adults.

• Established/approved use: Treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled on monotherapy with either a beta-blocker or a thiazide diuretic alone, or as an alternative to individual titration of the two components.
• Combination-therapy requirement: Nebivolol + Hydrochlorothiazide is not intended for initial therapy in patients whose blood pressure can be controlled on a single agent; it is generally used once patients have been assessed to require more than one class of antihypertensive.
• Guideline context: Combining a beta-1 selective blocker with a thiazide diuretic is a recognized guideline-supported strategy for achieving blood pressure targets when monotherapy is insufficient.

Nebivolol + Hydrochlorothiazide lowers blood pressure only; it does not treat the underlying cause of hypertension and does not replace lifestyle measures (diet, weight control, exercise, reduced salt intake) recommended alongside drug therapy.

General dosing principles

Nebivolol + Hydrochlorothiazide is taken by mouth, usually once daily, with or without food, at approximately the same time each day. Blood pressure should be reassessed periodically and the dose adjusted only under medical supervision.

Adult dosing

Renal impairment

Use with caution in patients with renal impairment. Thiazides may be less effective and are generally avoided when creatinine clearance is markedly reduced (e.g., below approximately 30 mL/min); a physician should individualize therapy in this setting.

Hepatic impairment

Nebivolol + Hydrochlorothiazide is contraindicated in severe hepatic impairment (see Contraindications). Use with caution and close monitoring in mild-to-moderate hepatic impairment.

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed dose should be skipped. Do not double the dose.

Discontinuation

Do not stop Nebivolol + Hydrochlorothiazide abruptly, particularly in patients with underlying coronary artery disease; the beta-blocker component should be tapered gradually over one to two weeks under medical guidance (see Precautions and Warnings).

Side effects of Nebivolol + Hydrochlorothiazide arise from either the beta-blocker or the thiazide diuretic component.

Common side effects

• Headache and dizziness
• Fatigue or tiredness
• Bradycardia (slow heart rate)
• Cold hands or feet
• Nausea
• Increased urination
• Muscle cramps

Less common but important side effects

• Electrolyte disturbances (low potassium, low sodium, low magnesium)
• Orthostatic (postural) hypotension, especially in the elderly or volume-depleted patients
• Worsening of blood glucose control in patients with diabetes
• Increased blood uric acid levels or gout flare
• Photosensitivity (increased skin sensitivity to sunlight)
• Erectile dysfunction
• Shortness of breath or bronchospasm in susceptible individuals

Patients should seek prompt medical attention for signs of a serious allergic reaction, severe dizziness or fainting, very slow heartbeat, significant swelling, or difficulty breathing.